Marcin Imielinski, M.D., Ph.D.

Genomic diagnostics enable a novel paradigm of cancer care in which patients are matched to appropriate treatments on the basis of genetic alterations in their tumor.  My Ph.D. training in computational biology and M.D. training in laboratory medicine uniquely positions me to tackle the challenges involved in incorporating complex genomic data into clinical practice.   As a member of Weill-Cornell Medicine and the Englander Institute for Precision Medicine, I look forward to ushering in an exciting future for "quantitative" pathology, where diagnosticians help drive therapeutic decision-making by integrating sophisticated data analyses with the intuition of a trained clinical eye.